GLP1R and Obesity: Besides obesity, this restorative potential of GLP-1 analogues has implications for other pathologies characterized by impaired dopaminergic function and associated with metabolic impairments, such as psychosis71, Parkinson’s disease72, depression73 or even cardiovascular events74.